Drug Target Review: Pinpointing function in cancer T cells could be new immunotherapy
UC research has found that increasing a certain function in cancer T cells could mean a new therapy
A previously unknown T cell mechanism that could explain the reason behind decreased immune function in cancer patients has been discovered. According to University of Cincinnati researchers, their finding may present a new immunotherapeutic target for patients with head and neck cancers.
The study, led by Laura Conforti and Ameet Chimote, in the Division of Nephrology and Hypertension, UC Department of Internal Medicine, revealed that a reduced interaction between a molecule called calmodulin and the ion channel KCa3.1 in the immune cells of cancer patients plays an important role in the limited function of these cells. The team performed experiments on cytotoxic T cells taken from the blood of patients with head and neck cancer.
Featured photo courtesy of Laura Conforti and Ameet Chimote.
Related Stories
UC Foundation celebrates 2026 philanthropy winners
October 23, 2026
The University of Cincinnati Foundation recognized its Outstanding Philanthropic Volunteer Award honorees at the George Rieveschl Recognition Dinner on October 22, 2026.
AI breast cancer survival model from Cancer Center could improve accuracy and personalize care
October 23, 2026
UC Cancer Center researchers, including lead author Wedad Alatebi, developed a deep learning survival model for breast cancer that combines detailed clinical and genetic information, potentially offering physicians a more accurate tool to guide treatment decisions.
UC expert explains potential impact of Pennsylvania’s new vape product law
October 22, 2026
UC professor Ashley Merianos speaks to the Pittsburgh Post-Gazette about Pennsylvania’s new vape law, youth vaping prevention, enforcement challenges and possible unintended consequences.